Detalhe da pesquisa
1.
Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer: GOTIC-019 study.
Int J Clin Oncol
; 28(6): 804-815, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140771
2.
Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma.
BMC Cancer
; 22(1): 59, 2022 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027024
3.
A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma.
J Pathol
; 255(3): 285-295, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322886
4.
Correlation between pre-operative and final histological diagnosis on endometrial cancer.
Int J Gynecol Cancer
; 29(5): 886-889, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826751
5.
[â ¢. Recent Trends in Chemotherapy, Targeted Therapy and Immunotherapy for Cervical Cancer and Promising New Treatments].
Gan To Kagaku Ryoho
; 49(2): 155-160, 2022 Feb.
Artigo
em Japonês
| MEDLINE | ID: mdl-35249050
6.
A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
Jpn J Clin Oncol
; 46(6): 517-21, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26977055
7.
Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Int J Gynecol Cancer
; 25(7): 1300-5, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26166556
8.
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial.
J Gynecol Oncol
; 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38178702
9.
Endometrial stromal sarcoma: clinicopathological and immunophenotypic study of 16 cases.
Arch Gynecol Obstet
; 288(2): 385-91, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23435725
10.
Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma.
J Ovarian Res
; 16(1): 93, 2023 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37179337
11.
Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy.
Clin Cancer Res
; 29(12): 2239-2249, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36976261
12.
A pilot study of mobile digital colposcopy in Japanese patients with cervical intraepithelial neoplasm.
Mol Clin Oncol
; 15(4): 207, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462663
13.
High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.
J Gynecol Oncol
; 31(6): e93, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078598
14.
MLH1 Is a Prognostic Biomarker for Serous Ovarian Cancer Treated With Platinum- and Taxane-based Chemotherapy.
Anticancer Res
; 39(10): 5505-5513, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570444
15.
A unique uterine cervical "teratocarcinosarcoma": a case report.
Diagn Pathol
; 14(1): 122, 2019 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31684979
16.
Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma.
Sci Rep
; 9(1): 2397, 2019 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787326